D.E. Shaw & Co’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$75.3K Sell
18,149
-923,048
-98% -$3.75M ﹤0.01% 4312
2025
Q4
$6.08M Buy
941,197
+915,697
+3,591% +$5.71M ﹤0.01% 2146
2025
Q3
$143K Sell
25,500
-39,176
-61% -$169K ﹤0.01% 4322
2025
Q2
$214K Sell
64,676
-114,359
-64% -$328K ﹤0.01% 4034
2025
Q1
$519K Buy
179,035
+52,571
+42% +$159K ﹤0.01% 3487
2024
Q4
$450K Buy
126,464
+95,418
+307% +$440K ﹤0.01% 3680
2024
Q3
$155K Buy
31,046
+20,858
+205% +$81.2K ﹤0.01% 4206
2024
Q2
$26.5K Sell
10,188
-85,025
-89% -$284K ﹤0.01% 4256
2024
Q1
$406K Buy
+95,213
New +$317K ﹤0.01% 3589
2022
Q3
Sell
-164,607
Closed -$106K 5171
2022
Q2
$106K Buy
164,607
+55,769
+51% +$74.2K ﹤0.01% 4714
2022
Q1
$284K Buy
108,838
+21,052
+24% +$61.5K ﹤0.01% 4679
2021
Q4
$341K Buy
+87,786
New +$441K ﹤0.01% 4618
2020
Q3
Sell
-283,418
Closed -$1.38M 3808
2020
Q2
$1.38M Buy
283,418
+69,196
+32% +$319K ﹤0.01% 2697
2020
Q1
$469K Sell
214,222
-49,195
-19% -$187K ﹤0.01% 3241
2019
Q4
$1.53M Buy
+263,417
New +$1.37M ﹤0.01% 2684

Other funds holding AQST